Physician profile
Saba Akhtar
NPI 1104112440
$1,931.28
in general payments reported to CMS, 2019-2025
15 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $66.49 · 2021: $176 · 2022: $199 · 2023: $299 · 2024: $362 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,134.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $398.73 | 2022-2025 | Teflaro, Dalvance |
| Merck Sharp & Dohme LLC | $316.05 | 2019-2025 | Zerbaxa, Recarbrio |
| Janssen Pharmaceuticals, INC | $289.54 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $232.82 | 2025 | Lifevest |
| Allergan, INC. | $188.52 | 2019 | |
| Pfizer INC. | $178.27 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.05 | 2021-2024 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Novartis Pharmaceuticals Corporation | $69.68 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $31.45 | 2025 | |
| Edwards Lifesciences Corporation | $24.54 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astrazeneca Pharmaceuticals LP | $24.45 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $22.51 | 2019 | |
| Phathom Pharmaceuticals, INC. | $20.42 | 2024 | Voquezna |
| Exact Sciences Corporation | $19.86 | 2025 | Cologuard Collection Kit |
| Amgen INC. | $14.39 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saba Akhtar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.